RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. AnaCardio

AnaCardio

AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.

Latest funding

$70.97M Series B+ ·

Led by Novo Holdings · Source: anacardio.com

Total raised: $89.97M across 2 sourced rounds

All 3 rounds ↓
Website: anacardio.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Medical.
Stage: Series B+.
Based in: Solna, Sweden.
Total raised: $89.97M in 2 sourced rounds.
Last round: Sep 30, 2026 · 47 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredApr 19, 2017 (9 years old)
TIMELINE · MONEY RAISED

AnaCardio | 1531 days on the record

Raised $90M in 2 sourced rounds
$22M$45M$67M$90MOCTMAYDECJULFEBSEPAPRNOV$90MSeries A · Sep 7, 2022A · SEP '22$19M Series A · Jan 9, 2025$19M A · JAN '25$70.97M Series B+ · Sep 30, 2026$70.97M B+ · SEP '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$70.97MNNovo Holdingsanacardio.com
Series A$19MNNovo Holdingsfundraisingfox.com
Series AundisclosedFFlerie Investfundraisingfox.com

Timeline

  1. Website created

Team

Investors

Companies like AnaCardio

Other companies backed by Novo Holdings

Novo Holdings portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/anacardio (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy